OBJECTIVE: To report the use of tetracyclines for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP). DESIGN: Observational case series. SETTING: . The Presley Regional Trauma Center located within the Regional Medical Center, Memphis, Tennessee, USA. PATIENTS AND PARTICIPANTS: Seven critically ill trauma patients with VAP caused by A. baumannii isolates that were resistant to all antibiotics tested except for doxycycline or minocycline. INTERVENTIONS: Patients were treated with IV doxycycline or minocycline for an average of 13.5 (range 9-20) days. MEASUREMENTS AND RESULTS: Doxycycline or minocycline was successful in six of seven patients. CONCLUSIONS: Doxycycline or minocycline may be effective for treating multidrug-resistant A. baumannii VAP.
OBJECTIVE: To report the use of tetracyclines for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP). DESIGN: Observational case series. SETTING: . The Presley Regional Trauma Center located within the Regional Medical Center, Memphis, Tennessee, USA. PATIENTS AND PARTICIPANTS: Seven critically ill traumapatients with VAP caused by A. baumannii isolates that were resistant to all antibiotics tested except for doxycycline or minocycline. INTERVENTIONS:Patients were treated with IV doxycycline or minocycline for an average of 13.5 (range 9-20) days. MEASUREMENTS AND RESULTS:Doxycycline or minocycline was successful in six of seven patients. CONCLUSIONS:Doxycycline or minocycline may be effective for treating multidrug-resistant A. baumannii VAP.
Authors: M E Jiménez-Mejías; B Becerril; F J Márquez-Rivas; C Pichardo; L Cuberos; J Pachón Journal: Eur J Clin Microbiol Infect Dis Date: 2000-12 Impact factor: 3.267
Authors: M E Jiménez-Mejías; J Pachón; B Becerril; J Palomino-Nicás; A Rodríguez-Cobacho; M Revuelta Journal: Clin Infect Dis Date: 1997-05 Impact factor: 9.079
Authors: J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho Journal: Clin Infect Dis Date: 1996-06 Impact factor: 9.079
Authors: X Corbella; J Ariza; C Ardanuy; M Vuelta; F Tubau; M Sora; M Pujol; F Gudiol Journal: J Antimicrob Chemother Date: 1998-12 Impact factor: 5.790
Authors: Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo Journal: Antimicrob Agents Chemother Date: 2007-07-23 Impact factor: 5.191
Authors: Mitchell G Thompson; Chad C Black; Rebecca L Pavlicek; Cary L Honnold; Matthew C Wise; Yonas A Alamneh; Jay K Moon; Jennifer L Kessler; Yuanzheng Si; Robert Williams; Suleyman Yildirim; Benjamin C Kirkup; Romanza K Green; Eric R Hall; Thomas J Palys; Daniel V Zurawski Journal: Antimicrob Agents Chemother Date: 2013-12-16 Impact factor: 5.191